Back to CVE records
Critical 9.8Published Dec 24, 2025

CVE-2025-68741In the Linux kernel, the following vulnerability has been resolved: scsi: qla2xxx: Fix improper freeing of purex item In qla2xxx_process_purls_iocb(), an item is allocated via qla27xx_copy_multiple_p…

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

In the Linux kernel, the following vulnerability has been resolved: scsi: qla2xxx: Fix improper freeing of purex item In qla2xxx_process_purls_iocb(), an item is allocated via qla27xx_copy_multiple_pkt(), which internally calls qla24xx_alloc_purex_item(). The qla24xx_alloc_purex_item() function may return a pre-allocated item from a per-adapter pool for small allocations, instead of dynamically allocating memory with kzalloc(). An error handling path in qla2xxx_process_purls_iocb() incorrectly uses kfree() to release the item. If the item was from the pre-allocated pool, calling kfree() on it is a bug that can lead to memory corruption. Fix this by using the correct deallocation function, qla24xx_free_purex_item(), which properly handles both dynamically allocated and pre-allocated items.

CVSS
9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
Not given
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Deferred
Record last updated
Oct 13, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.